Scaling up prevention, testing and treatment services could eliminate hepatitis C as a public health threat. The World Health Organization’s target is for countries to reduce infections by 90% and hepatitis-related mortality by 65%, by 2030.

Elimination of hepatitis C: latest news

Elimination of hepatitis C news from aidsmap

More news

Elimination of hepatitis C news selected from other sources

  • India: National action plan for free treatment of hepatitis patients launched

    National action plan for free treatment of hepatitis patients launched  The HinduEnvisages model treatment centres in all States in the first year.

    27 February 2019 | The Hindu
  • Expert working group recommends bold action to eliminate hepatitis C in Scotland; now we need a national elimination strategy

    A new report published by Health Protection Scotland sets out national recommendations for improvements to case finding and access to care which would accelerate Scotland’s efforts to eliminate hepatitis C. The Hepatitis C Trust calls on the Scottish Government to set out a clear timeline and process for developing and releasing a national elimination strategy for hepatitis C, in order to facilitate implementation of the recommendations contained in the recent Health Protection Scotland report.

    19 February 2019 | Hepatitis C Trust
  • England: Countdown to hep C eradication

    NHS England’s target date to eliminate hepatitis C is now just six years away. DDN hears what progress has been made, and what’s left to achieve, at the LJWG on Substance Use and Hepatitis C annual conference.

    05 February 2019 | Drink & Drug News
  • UK court dismisses AbbVie's legal challenge against the NHS

    The High Court has dismissed a legal challenge by US pharmaceutical firm AbbVie against the National Health Service (NHS) England's procurement deal for drugs to treat and cure hepatitis C. The decision means that the plan to eliminate the virus in England remains on track.

    25 January 2019 | The Lancet (free registration required)
  • NHS England’s plan to eliminate Hepatitis C decisively backed by High Court

    NHS England’s plan to eliminate Hepatitis C in England by 2025 is on track after all aspects of a High Court challenge by pharmaceutical company AbbVie were dismissed. The NHS’s single largest medicines procurement, a deal worth almost £1 billion over five years, was launched in April last year but contract start dates had to be delayed by six months after legal action by AbbVie.

    18 January 2019 | NHS England
  • Egypt proposes plan to treat African Hepatitis C patients

    Minister of Health Hala Zayed unveiled an Egyptian initiative to treat African people from Hepatitis C, starting with the Nile Basin countries who have an estimated 3.7 million hepatitis C patients, representing 30 percent of the total number of infected people in Africa.

    16 January 2019 | Egypttoday
  • Hepatitis C in England: 2018 report

    In this report, we summarise the impact of action plans in England to drive down mortality from HCV, reduce the number of new infections, and outline the actions required to make further progress.

    08 May 2018 | Public Health England
  • Eliminating Hepatitis C in England

    England will not fulfil its commitment to elimination of hepatitis C by 2030 unless the number of people diagnosed and initiated onto treatment is greatly increased.

    23 March 2018 | All-Party Parliamentary Group on Liver Health
  • Systematic Hep C Test-and-Treat Lowers Rate in Gay Men With HIV

    A Swiss research program tested for and treated hep C in a large cohort of HIV-positive men who have sex with men over time.

    22 March 2018 | Poz
  • WHO urges countries to scale up hepatitis C treatment

    A new WHO report shows that the annual number of people receiving hepatitis C cure increased from around 1 million in 2015 to 1.5 million in 2016. However, global access to hepatitis C treatment remains uneven, with Egypt and Pakistan accounting for about half of all people starting direct-acting antiviral (DAA) treatment to cure hepatitis C in 2016.

    09 March 2018 | World Health Organization
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.